Germo Gericke
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
- Oncology 5
- Lung Cancer Research Studies 3
- Cancer Immunotherapy and Biomarkers 1
-
- Prostate Cancer Treatment and Research 2
- Lung Cancer Treatments and Mutations 1
- Photodynamic Therapy Research Studies 1
- Co-authors
- Bernd J. Krause (2 shared papers)Karim Fizazi (2 shared papers)Michelle DeSilvio (2 shared papers)Johann S. de Bono (2 shared papers)Chandler H. Park (2 shared papers)Kim N. (2 shared papers)Scott T. Tagawa (2 shared papers)Kambiz Rahbar (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Research (1 paper)Journal of Nuclear Medicine (1 paper)New England Journal of Medicine (1 paper)Cytometry (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Germo Gericke
6 papers receiving 1.7k citations
Germo Gericke's Hit Papers
Peers
Comparison fields: 5 of 72
- Radiology, Nuclear Medicine and Imaging 837
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 467
- Cancer Research 145
- Radiation 47
Countries citing papers authored by Germo Gericke
This map shows the geographic impact of Germo Gericke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Germo Gericke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Germo Gericke more than expected).
Fields of papers citing papers by Germo Gericke
This network shows the impact of papers produced by Germo Gericke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Germo Gericke. The network helps show where Germo Gericke may publish in the future.
Co-authors
The 25 scholars most cited alongside Germo Gericke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2021 | 1582 |
| 2 | 2021 | 56 | |
| 3 | 2021 | 48 | |
| 4 | 2025 | 7 | |
| 5 | 2025 | 1 | |
| 6 | 1998 | 1 |
About Germo Gericke
Germo Gericke is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Neurology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 6 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (3 papers), Prostate Cancer Treatment and Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Neuroblastoma Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Photodynamic Therapy Research Studies (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (837 citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (467 citations), Cancer Research (145 citations) and Radiation (47 citations). Germo Gericke has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Bernd J. Krause, Karim Fizazi, Michelle DeSilvio, Johann S. de Bono, Chandler H. Park, Kim N., Scott T. Tagawa, Kambiz Rahbar, Ken Herrmann and Ghassan El‐Haddad. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal of Nuclear Medicine, New England Journal of Medicine and Cytometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.